Recombinant oncolytic poliovirus, PVSRIPO, has potent cytotoxic and innate inflammatory effects, mediating therapy in human breast and prostate cancer xenograft models.
about
Recombinant oncolytic poliovirus, PVSRIPO, has potent cytotoxic and innate inflammatory effects, mediating therapy in human breast and prostate cancer xenograft models.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 October 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Recombinant oncolytic poliovir ...... state cancer xenograft models.
@en
Recombinant oncolytic poliovir ...... state cancer xenograft models.
@nl
type
label
Recombinant oncolytic poliovir ...... state cancer xenograft models.
@en
Recombinant oncolytic poliovir ...... state cancer xenograft models.
@nl
prefLabel
Recombinant oncolytic poliovir ...... state cancer xenograft models.
@en
Recombinant oncolytic poliovir ...... state cancer xenograft models.
@nl
P2093
P2860
P921
P356
P1433
P1476
Recombinant oncolytic poliovir ...... state cancer xenograft models.
@en
P2093
Daniel J George
David Boczkowski
Eda K Holl
Matthias Gromeier
Megan A McNamara
Smita K Nair
P2860
P304
79828-79841
P356
10.18632/ONCOTARGET.12975
P407
P577
2016-10-28T00:00:00Z